{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T19:27:52Z","timestamp":1768678072586,"version":"3.49.0"},"reference-count":77,"publisher":"Baishideng Publishing Group Inc.","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJH"],"published-print":{"date-parts":[[2013]]},"DOI":"10.4254\/wjh.v5.i11.612","type":"journal-article","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T09:50:24Z","timestamp":1509616224000},"page":"612","source":"Crossref","is-referenced-by-count":24,"title":["Hepatitis B virus reactivation with rituximab-containing regimen"],"prefix":"10.4254","volume":"5","author":[{"given":"Yutaka","family":"Tsutsumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiya","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joji","family":"Shimono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ohhigashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Teshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Maloney DG, Liles TM, Czerwinski DK, Waldichuk C, Rosenberg J, Grillo-Lopez A, Levy R. Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma. Blood 1994;84:2457-2466.","DOI":"10.1182\/blood.V84.8.2457.2457"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Maloney DG, Grillo-L&oacute;pez AJ, White CA, Bodkin D, Schilder RJ, Neidhart JA, Janakiraman N, Foon KA, Liles TM, Dallaire BK. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin&rsquo;s lymphoma. Blood 1997;90:2188-2195.","DOI":"10.1182\/blood.V90.6.2188"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Maloney DG, Grillo-L&oacute;pez AJ, Bodkin DJ, White CA, Liles TM, Royston I, Varns C, Rosenberg J, Levy R. IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin&rsquo;s lymphoma. J Clin Oncol 1997;15:3266-3274.","DOI":"10.1200\/JCO.1997.15.10.3266"},{"key":"ref4","unstructured":"Berm&uacute;dez A, Marco F, Conde E, Mazo E, Recio M, Zubizarreta A. Fatal visceral varicella-zoster infection following rituximab and chemotherapy treatment in a patient with follicular lymphoma. Haematologica 2000;85:894-895."},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Sharma VR, Fleming DR, Slone SP. Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab. Blood 2000;96:1184-1186.","DOI":"10.1182\/blood.V96.3.1184"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200109273451315"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.4.1486"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Galbraith RM, Eddleston AL, Williams R, Zuckerman AJ. Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy. Lancet 1975;2:528-530.","DOI":"10.1016\/S0140-6736(75)90897-1"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-96-4-447"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1985.00360070195034"},{"key":"ref11","unstructured":"Lau JY, Lai CL, Lin HJ, Lok AS, Liang RH, Wu PC, Chan TK, Todd D. Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients. Q J Med 1989;73:911-917."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2900080504"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.4.3.599"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-008-0585-6"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402567"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1403"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200101043440120"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s002770100346"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2002.01692.x"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1080\/1042819031000151923"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-003-0748-4"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-007-0396-1"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5415.825"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.19324"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Lok AS, Liang RH, Chiu EK, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991;100:182-188.","DOI":"10.1016\/0016-5085(91)90599-G"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Nakamura Y, Motokura T, Fujita A, Yamashita T, Ogata E. Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies. Survey in Japan, 1987-1991. Cancer 1996;78:2210-2215.","DOI":"10.1002\/(SICI)1097-0142(19961115)78:10<2210::AID-CNCR24>3.0.CO;2-0"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/8.suppl_1.S107"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Yeo W, Chan PK, Zhong S, Ho WM, Steinberg JL, Tam JS, Hui P, Leung NW, Zee B, Johnson PJ. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors. J Med Virol 2000;62:299-307.","DOI":"10.1002\/1096-9071(200011)62:3<299::AID-JMV1>3.0.CO;2-0"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.04.015"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(02)00773-8"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.0182"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601699"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.48.5938"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.45.1590"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.45.0158"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-148-7-200804010-00008"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Lau GK, Yiu HH, Fong DY, Cheng HC, Au WY, Lai LS, Cheung M, Zhang HY, Lie A, Ngan R. Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy. Gastroenterology 2003;125:1742-1749.","DOI":"10.1053\/j.gastro.2003.09.026"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.01847.x"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.2.391"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-004-0725-1"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-008-0454-3"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1159\/000046631"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10043"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Kami M, Hamaki T, Murashige N, Kishi Y, Kusumi E, Yuji K, Miyakoshi S, Ueyama J, Morinaga S, Mutou Y. Safety of rituximab in lymphoma patients with hepatitis B or hepatitis C virus infection. Hematol J 2003;4:159-162.","DOI":"10.1038\/sj.thj.6200243"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20110"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.29401"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1038\/sj.thj.6200396"},{"key":"ref48","unstructured":"Picardi M, Pane F, Quintarelli C, De Renzo A, Del Giudice A, De Divitiis B, Persico M, Ciancia R, Salvatore F, Rotoli B. Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin&rsquo;s lymphomas: high prevalence of acquired viral genomic mutations. Haematologica 2003;88:1296-1303."},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21311"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21513"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2005.01134.x"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.10.001"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2002.00344.x"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh430"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2006.10.006"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000151661.52601.FB"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-012-1405-6"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-012-1050-9"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.tracli.2003.11.007"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-163493"},{"key":"ref61","unstructured":"Christensen PB, Clausen MR, Krarup H, Laursen AL, Schlichting P, Weis N. Treatment for hepatitis B virus (HBV) and hepatitis C virus (HCV) infection - Danish national guidelines 2011. Dan Med J 2012;59:C4465."},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2008.00936.x"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Reff ME, Carner K, Chambers KS, Chinn PC, Leonard JE, Raab R, Newman RA, Hanna N, Anderson DR. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 1994;83:435-445.","DOI":"10.1182\/blood.V83.2.435.435"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21051"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"McLaughlin P, Grillo-L&oacute;pez AJ, Link BK, Levy R, Czuczman MS, Williams ME, Heyman MR, Bence-Bruckler I, White CA, Cabanillas F. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol 1998;16:2825-2833.","DOI":"10.1200\/JCO.1998.16.8.2825"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Tobinai K, Kobayashi Y, Narabayashi M, Ogura M, Kagami Y, Morishima Y, Ohtsu T, Igarashi T, Sasaki Y, Kinoshita T. Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma. The IDEC-C2B8 Study Group. Ann Oncol 1998;9:527-534.","DOI":"10.1023\/A:1008265313133"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1007\/BF02981940"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-004-0899-y"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21214"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07451.x"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.05.037"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.10.051"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200501203520324"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(03)00364-7"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1186\/ar1954"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2010.02332.x"}],"container-title":["World Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1948-5182\/full\/v5\/i11\/612.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:11:38Z","timestamp":1603239098000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1948-5182\/full\/v5\/i11\/612.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":77,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.4254\/wjh.v5.i11.612","relation":{},"ISSN":["1948-5182"],"issn-type":[{"value":"1948-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}